A recent study demonstrated that GRSF1 drives tumorigenesis and EMT-mediated metastasis in gastric cancer by activating the PI3K/AKT pathway, and may also facilitate immune evasion through modulation of the tumor immune microenvironment (46). Here, AKT1 is linked to gastric cancer.